Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients With Advanced Neuroendocrine Tumors.
Article in JCO Oncology Practice (June 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in JCO Oncology Practice (June 2024)
Article in Radiology and Oncology (June 2024)
Article in Frontiers in Oncology (May 2024)